Internal Medicine · Brooklyn, NY
NPI
1639138654
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
231 S 3rd St
Brooklyn, NY, 11211
Phone (718) 599-0505
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
564 services
Medicare patients, 2024
132
Average age 75
Drug cost, 2024
$7.0M
39,557 prescriptions
Company payments, 2025
$1,604
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sixto R Caro was code 99214 (office e&m - established), 141 times for 83 patients. In total Sixto R Caro billed 564 services in 18 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-01-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 141 | 83 | $90.64 | $13K |
| G2012 Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 131 | 70 | $8.81 | $1,154 |
| 93000 Electrocardiogram | Office | 63 | 56 | $9.18 | $578 |
| 99213 Office E&M - Established | Office | 62 | 44 | $72.97 | $4,524 |
| 99211 Office E&M - Established | Office | 45 | 26 | $18.43 | $829 |
| 90662 Vaccine Product | Office | 29 | 27 | $80.80 | $2,343 |
| G0008 Administration of influenza virus vaccine | Office | 26 | 26 | $36.87 | $959 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 20 | 20 | $145.93 | $2,919 |
| 99212 Office E&M - Established | Office | 19 | 19 | $29.50 | $561 |
By year: 2022 $39K for 784 services; 2023 $32K for 614 services; 2024 $27K for 564 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sixto R Caro prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,732 prescriptions and refills. In total Sixto R Caro wrote 39,557 Medicare prescriptions that cost $7.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,732 | 4,711 | 492 | $20K |
| Montelukast Sodium Generic | 1,250 | 2,964 | 355 | $12K |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 1,054 | 1,691 | 249 | $1,346 |
| Amlodipine Besylate Generic | 1,005 | 2,723 | 275 | $5,681 |
| Omeprazole Generic | 903 | 2,311 | 278 | $12K |
| Losartan Potassium Generic | 766 | 2,150 | 221 | $7,334 |
| Alcohol Prep Pads Alcohol Antiseptic Pads | 741 | 1,829 | 256 | $14K |
| Levothyroxine Sodium Generic | 723 | 1,922 | 184 | $12K |
| Diclofenac Sodium Generic | 693 | 1,378 | 237 | $37K |
| Farxiga Dapagliflozin Propanediol | 678 | 1,100 | 146 | $600K |
| Metformin Hcl Generic | 676 | 1,757 | 190 | $3,350 |
| Dexlansoprazole Dr Dexlansoprazole | 668 | 1,747 | 166 | $220K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 642 | 1,211 | 166 | $38K |
| Rosuvastatin Calcium Generic | 620 | 1,782 | 197 | $8,152 |
| Famotidine Generic | 600 | 1,456 | 176 | $29K |
Brand drugs: 8,921 claims; generic drugs: 29,210 claims; opioid claims: 268.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sixto R Caro $1,604 ($1,604 in general payments such as food, travel and fees) from 19 companies. The largest payer was Gilead Sciences, Inc. with $308.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 9 | $308 |
| AstraZeneca Pharmaceuticals LP AZN | 10 | $220 |
| Exact Sciences Corporation EXAS | 6 | $135 |
| Phathom Pharmaceuticals, Inc. PHAT | 4 | $111 |
| Merck Sharp & Dohme LLC MRK | 4 | $106 |
| Lilly USA, LLC LLY | 4 | $105 |
| Pfizer Inc. PFE | 4 | $84.11 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $70.77 |
| Novo Nordisk Inc NVO | 3 | $70.03 |
| Ardelyx, Inc. ARDX | 3 | $67.27 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.